Cai Wenbin W - OmicsDI

Show results for

Metabolomics (3)

Repository

MetaboLights (3)

Technology Type

Mass spectrometry (3)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (2)
Liquid Chromatography MS - negative (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive (1)

Publication Date

2021 (2)
2022 (1)

CHEBI ID

CHEBI:16113 (2)
CHEBI:10333 (1)
CHEBI:127309 (1)
CHEBI:1296 (1)
CHEBI:1301 (1)
CHEBI:131428 (1)
CHEBI:131430 (1)
CHEBI:131439 (1)
CHEBI:131440 (1)
CHEBI:131590 (1)
CHEBI:131988 (1)
CHEBI:132503 (1)
CHEBI:132539 (1)
CHEBI:132543 (1)
CHEBI:132547 (1)
CHEBI:132576 (1)
CHEBI:132579 (1)
CHEBI:132580 (1)
CHEBI:132581 (1)
CHEBI:132582 (1)
CHEBI:132603 (1)
CHEBI:132620 (1)
CHEBI:132745 (1)
CHEBI:132773 (1)
CHEBI:132823 (1)
CHEBI:133599 (1)
CHEBI:133617 (1)
CHEBI:133624 (1)
CHEBI:134239 (1)
CHEBI:134242 (1)

Metabolite Name

(20,23-cyclo)-cholest-5-en-3beta-ol (1)
(20R)-3beta-hydroxy-5alpha-cholesta-8,24-diene-4-carbaldehyde (1)
(22,23-dinor)-24-vinyl-cholest-5-en-3beta,24-diol (1)
(22R,23R)-methylene-cholest-5-en-3beta-ol (1)
(24R)-cholest-5-en-3beta,24-diol (1)
(24S)-26-nor-5alpha-cholest-22E-en-3beta-ol (1)
(25R)-24R,26R-dimethyl-26,27-cyclo-5alpha-cholestan-3beta-ol (1)
(25R)-24R,26R-dimethyl-26,27-cyclo-cholest-5-en-3beta-ol (1)
(25S)-24R,26-dimethylcholest-5-en-3beta-ol (1)
(25S)-24S,26-cyclocholest-5-en-3beta-ol (1)
(25S)-5alpha-spirostan-3beta-ol (1)
(25S)-5beta-spirostan-3beta-ol (1)
(3S,6R)-9,10-seco-5(10),6,7-cholestatrien-3-ol (1)
(3S,6R,9R)-9(10-6)abeo-5(10),7-cholestadien-3-ol (1)
(3S,6S)-9,10-seco-5(10),6,7-cholestatrien-3-ol (1)
(3beta,22R)-stigmasta-4,6-diene-3,22-diol (1)
(5E,7E)-(3S)-6-fluoro-9,10-seco-5,7,10(19)-cholestatrien-3-ol (1)
(5E,7E)-(3S,22R)- 24-nor-9,10-seco-5,7,10(19)-cholatriene-3,22-diol (1)
(5E,7E,10E)-(3S)-19-methyl-9,10-seco-5,7,10(19)-cholestatrien-3-ol (1)
(5E,7E,22E)-(3S,10S)-9,10-seco-5,7,22-ergostatrien-3-ol (1)
(5Z,7E)-(1S,3R)-1,3,21-trihydroxy-9,10-seco-5,7,10(19)-pregnatrien-20-one (1)
(5Z,7E)-(1S,3R)-22-oxa-9,10-seco-5,7,10(19)-cholestatriene-1,3-diol (1)
(5Z,7E)-(1S,3R)-23,24-dinor-9,10-seco-5,7,10(19)-cholatriene-1,3-diol (1)
(5Z,7E)-(3S)-22-fluoro-9,10-seco-5,7,10(19)-cholestatrien-3-ol (1)
(5Z,7E)-(3S)-23,23-difluoro-9,10-seco-5,7,10(19)-cholestatriene-3,25-diol (1)
(5Z,7E)-(3S)-23,24-dinor-9,10-seco-5,7,10(19)-cholatrien-3,22-diol (1)
(5Z,7E)-(3S)-25-fluoro-9,10-seco-5,7,10(19)-cholestatrien-3-ol (1)
(5Z,7E)-(3S,22R)- 24-nor-9,10-seco-5,7,10(19)-cholatriene-3,22-diol (1)
(5Z,7E)-(3S,22S)- 24-nor-9,10-seco-5,7,10(19)-cholatriene-3,22-diol (1)
(5Z,7E,10E)-(3S)-19-methyl-9,10-seco-5,7,10(19)-cholestatrien-3-ol (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Different regions of synaptic vesicle membrane regulate VAMP2 conformation for the SNARE assembly

Vesicle associated membrane protein 2 (VAMP2/synaptobrevin2), a core SNARE protein residing on synaptic vesicles (SVs), forms helix bundles with syntaxin-1 and SNAP25 for the SNARE assembly. Prior to the SNARE assembly, the structure of VAMP2 is unclear. Here, by using in-cell NMR spectroscopy, we d...

2021-10-06 | MTBLS1503 | MetaboLights

Ion mobility-based sterolomics reveals spatially and temporally distinctive sterol lipids in the mouse brain

Aberrant sterol lipid metabolism is associated with physiological dysfunctions in the aging brain and aging-dependent disorders such as neurodegenerative diseases. There is an unmet demand to comprehensively profile sterol lipids spatially and temporally in different brain regions during aging. Here...

2021-05-24 | MTBLS2457 | MetaboLights

Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection

In this study, lipid alterations in Beagle dog’s liver caused by Toxocara canis infection were investigated by using liquid chromatography with tandem mass spectrometry at 12 hours post infection (hpi), 24 hpi and 36 days post infection (dpi). A total of 6 categories and 42 subclasses of...

2022-08-30 | MTBLS4015 | MetaboLights

Previous page
1 / 1
You're on page 1
Next page